"Designing Growth Strategies is in our DNA"

U.S. Botulinum Toxin Market Size, Share & Industry Analysis, By Application (Therapeutics {Chronic Migraine, Spasticity, Overactive Bladder, Cervical Dystonia, Blepharospasm, and Others}, and Aesthetics {Forehead Wrinkles, Glabellar Lines, Crow's Feet, and Others}), By Type (Botulinum Toxin Type A and Botulinum Toxin Type B), By End-user (Specialty & Dermatology Clinics, Hospitals & Clinics, and Others) and Forecast, 2023-2030

Last Updated: February 24, 2025 | Format: PDF | Report ID: FBI107506

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Overview of the Regulatory Scenario
    2. Pricing Analysis
    3. Overview of the Types of Botulinum Toxin
    4. Pipeline Analysis, Key Players
    5. Key Industry Developments
    6. Overview of Therapeutic Applications of Botulinum Toxin and Recent Regulatory Approvals
    7. Overview of the Reimbursement Scenario
    8. Impact of COVID-19 on the U.S. Botulinum Toxin Market
  5. U.S. Botulinum Toxin Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Application
      1. Therapeutics
        1. Chronic Migraine
        2. Spasticity
        3. Overactive Bladder
        4. Cervical Dystonia
        5. Blepharospasm
        6. Others
      2. Aesthetics
    2. Market Analysis, Insights and Forecast – By Type
      1. Botulinum Toxin Type A
      2. Botulinum Toxin Type B
    3. Market Analysis, Insights and Forecast – By End-user
      1. Specialty & Dermatology Clinics
      2. Hospitals & Clinics
      3. Others 
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
      1. AbbVie Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      2. Ipsen Pharma
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      3. Revance Therapeutics, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      4. Merz Pharma
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      5. Medytox
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      6. GALDERMA
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      7. HUGEL, Inc
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability).
      8. Evolus, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      9. Supernus Pharmaceuticals, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
Read Less

Table 01: U.S. Botulinum Toxin Market Revenue (USD billion) Forecast, By Application, 2019–2030

Table 02: U.S. Botulinum Toxin Market Revenue (USD billion) Forecast, By Therapeutics, 2019–2030

Table 03: U.S. Botulinum Toxin Market Revenue (USD billion) Forecast, By Type, 2019–2030

Table 04: U.S. Botulinum Toxin Market Revenue (USD billion) Forecast, By End User, 2019–2030

 

Figure 01: U.S. Botulinum Toxin Market Value Share (%), By Application, 2022 & 2030

Figure 02: U.S. Botulinum Toxin Market Value Share (%), By Type, 2022 & 2030

Figure 03: U.S. Botulinum Toxin Market Value Share (%), By End-user, 2022 & 2030

U.S. Botulinum Toxin Market Size, Share and Global Industry Trend Forecast till 2030
  • 2019-2030
  • 2022
  • 2019-2021
  • 80
Consulting Services
    How will you benefit from our consulting services ?